Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...

A new study finds that combining the COVID vaccine with immunotherapy may nearly double cancer survival rates — patients ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...

The use of immunotherapy in patients with various types of cancer has led to dramatic increases in survival. Increased median ...

Alecensa (alectinib) demonstrated a 22% reduction in the risk of death compared with Xalkori (crizotinib) in the frontline ...

IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical ...

A study has found that COVID-19 mRNA vaccines unexpectedly enhance the effectiveness of immunotherapy for lung and skin ...

Lung adenocarcinoma (LUAD) is the most common form of lung cancer, accounting for nearly half of cases. Many patients are ...

Lung cancer among nonsmokers is associated with germline risk factors, and EGFR/ALK-targeted therapies provide substantial ...

Thanks to recent therapy advances, the lung cancer mortality rate has declined and survival rates have improved. Many factors influence the likelihood of a lung cancer cure or long-term survival, ...

Patients with lung or skin cancers who received a COVID-19 messenger RNA vaccine within 100 days of beginning immunotherapy ...